Authors: TARTAGLIA J EXCLER JL ELHABIB R LIMBACH K MEIGNIER B PLOTKIN S KLEIN M

Citation: J. Tartaglia et al., CANARYPOX VIRUS-BASED VACCINES - PRIME-BOOST STRATEGIES TO INDUCE CELL-MEDIATED AND HUMORAL IMMUNITY AGAINST HIV, AIDS research and human retroviruses, 14, 1998, pp. 291-298

Authors: BENSON J CHOUGNET C ROBERTGUROFF M MONTEFIORI D MARKHAM P SHEARER G GALLO RC CRANAGE M PAOLETTI E LIMBACH K VENZON D TARTAGLIA J FRANCHINI G

Citation: J. Benson et al., RECOMBINANT VACCINE-INDUCED PROTECTION AGAINST THE HIGHLY PATHOGENIC SIMIAN IMMUNODEFICIENCY VIRUS SIVMAC251 - DEPENDENCE ON ROUTE OF CHALLENGE EXPOSURE, Journal of virology, 72(5), 1998, pp. 4170-4182

Authors: ANDERSSON S MAKITALO B THORSTENSSON R FRANCHINI G TARTAGLIA J LIMBACH K PAOLETTI E PUTKONEN P BIBERFELD G

Citation: S. Andersson et al., IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 RECOMBINANT CANARYPOX (ALVAC) VACCINE CANDIDATE IN CYNOMOLGUS MONKEYS, The Journal of infectious diseases, 174(5), 1996, pp. 977-985

Authors: FRANCHINI G ROBERTGUROFF M TARTAGLIA J AGGARWAL A ABIMIKU A BENSON J MARKHAM P LIMBACH K HURTEAU G FULLEN J ALDRICH K MILLER N SADOFF J PAOLETTI E GALLO RC

Citation: G. Franchini et al., HIGHLY ATTENUATED HIV TYPE-2 RECOMBINANT POXVIRUSES, BUT NOT HIV-2 RECOMBINANT SALMONELLA VACCINES, INDUCE LONG-LASTING PROTECTION IN RHESUS MACAQUES, AIDS research and human retroviruses, 11(8), 1995, pp. 909-920

Authors: FRANCHINI G GUROFF M TARTAGLIA J AGGARAWAL A ABIMIKU A MARKHAM P LIMBACH K SADOFF HJ PAOLETTI E GALLO RC

Citation: G. Franchini et al., PRIME BOOST PROTOCOLS UTILIZING HIGHLY ATTENUATED POXVIRUS VECTORS CONFER PROTECTION AGAINST HIV-2 CHALLENGE/, AIDS research and human retroviruses, 10, 1994, pp. 190000043-190000043